Eli Lilly and Company
Chairman, President and Chief Executive Officer
Sidney Taurel is Chairman, President and Chief Executive Officer of Eli Lilly and Company.
Taurel joined the Lilly subsidiary, Eli Lilly International Corporation, in 1971. Over the next several years, he held a number of positions in marketing, sales, and management, including posts in Latin America, Eastern Europe, and France. Taurel became Chief Executive Officer in 1998 and Chairman of the Board in 1999. He has served on the company’s Board of Directors since 1991.
A past chairman of the Pharmaceutical Research and Manufacturers of America, Taurel currently serves as a member of the Executive Committee of the trade association’s Board of Directors. Taurel is a member of the Board of Directors of IBM Corporation and the McGraw-Hill Companies, Inc. He serves on the Board of Overseers for the Columbia Business School, the Board of Trustees for the Indianapolis Museum of Art, and the Board of Directors for the RCA Tennis Championships. In addition, Taurel is a member of The Business Roundtable and The Business Council and serves on the President’s Homeland Security Advisory Council.
Born in Casablanca, Morocco, Taurel graduated from École des Hautes Études Commerciales, in Paris, France, in 1969 and received an M.B.A. from Columbia University in 1971.
Eli Lilly and Company
Eli Lilly and Company is a global innovation-driven pharmaceutical corporation, based in Indianapolis, Indiana. Lilly employs more than 41,000 people worldwide, markets its medicines in 158 countries, and posted sales of $11.5 billion in 2001. By applying the latest research from its own laboratories, collaborating with scientific organizations around the world, and using the most current technological tools, Lilly is developing a growing portfolio of best-in-class — often first-in-class — pharmaceutical products to meet the world’s most urgent unmet medical needs. The company operates research and joint-venture facilities in nine countries, conducts clinical research in more than 60 countries, and has manufacturing operations in 14 countries.
In 2002, Lilly was named on Forbes 500 list for the fourth consecutive year and climbed five spots on the Fortune 500. Earlier this year, Lilly was named among the “100 Best Corporate Citizens” by Business Ethics magazine.